1. Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors. Issue 2 (6th November 2019) Authors: Piha-Paul, Sarina A; Hann, Christine L; French, Christopher A; Cousin, Sophie; Braña, Irene; Cassier, Phillippe A; Moreno, Victor; de Bono, Johann S; Harward, Sara Duckworth; Ferron-Brady, Geraldine; Barbash, Olena; Wyce, Anastasia; Wu, Yuehui; Horner, Thierry; Annan, Meg; Parr, Nigel J; Prinjha,... Journal: JNCI cancer spectrum Issue: Volume 4:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗